Elevation Oncology Inc (ELEV)
0.3464 -0.0096 (-2.70%) 04/29/25 [NASDAQ]
0.3464 x 300 0.3650 x 1,000
Realtime by (Cboe BZX)
0.3464 x 300 0.3650 x 1,000
Realtime - - (-) -
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select FieldsSymbol | ELEV | LEXX | QTTB | ||
Company | Elevation Oncology Inc | Lexaria Bioscience Corp | Q32 Bio Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 0.3535 | 1.2100 | 1.6900 | ||
High | 0.3591 | 1.2400 | 1.7200 | ||
Low | 0.3416 | 1.1600 | 1.5000 | ||
Last | 0.3464 | 1.1700 | 1.5550 | ||
Change | -0.0096 | -0.0500 | -0.1300 | ||
% Change | -2.70% | -4.10% | -7.72% | ||
Volume | 450,000 | 90,800 | 310,700 | ||
20-Day Average Volume | 1,154,645 | 91,950 | 206,865 | ||
Previous Close | 0.3560 | 1.2200 | 1.6850 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | No | ||
Technicals | |||||
20-Day Moving Average | 0.3105 | 1.4280 | 1.7682 | ||
20-Day Raw Stochastic | 71.70% | 1.85% | 22.73% | ||
20-Day Relative Strength | 45.68% | 39.23% | 36.72% | ||
Weighted Alpha | -69.63 | -74.34 | -76.38 | ||
Today's Opinion | 80% Sell | 100% Sell | 100% Sell | ||
Previous Opinion | 80% Sell | 96% Sell | 96% Sell | ||
Last Month's Opinion | 100% Sell | 56% Sell | 100% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -6.88% since 04/22/25 | -19.86% since 04/22/25 | -18.59% since 04/22/25 | ||
Low | 0.3416 on 04/29/25 | 1.1600 on 04/29/25 | 1.5000 on 04/29/25 | ||
High | 0.3900 on 04/23/25 | 1.6900 on 04/24/25 | 1.9950 on 04/25/25 | ||
1-Month | |||||
%Chg | +33.23% since 03/28/25 | -31.98% since 03/28/25 | -9.06% since 03/28/25 | ||
Low | 0.2210 on 04/09/25 | 1.1600 on 04/29/25 | 1.3800 on 04/09/25 | ||
High | 0.3959 on 04/22/25 | 1.7500 on 03/31/25 | 2.1500 on 04/21/25 | ||
3-Month | |||||
%Chg | -43.99% since 01/29/25 | -35.36% since 01/29/25 | -51.71% since 01/29/25 | ||
Low | 0.2210 on 04/09/25 | 1.1500 on 03/04/25 | 1.3800 on 04/09/25 | ||
High | 0.7394 on 01/31/25 | 1.9110 on 02/07/25 | 3.4700 on 01/30/25 | ||
6-Month | |||||
%Chg | -41.59% since 10/29/24 | -50.42% since 10/29/24 | -96.71% since 10/29/24 | ||
Low | 0.2210 on 04/09/25 | 1.1500 on 03/04/25 | 1.3800 on 04/09/25 | ||
High | 0.9800 on 01/13/25 | 2.8499 on 12/04/24 | 51.2569 on 11/07/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 21,084 | 21,422 | 20,554 | ||
Shares Outstanding, K | 59,224 | 17,559 | 12,198 | ||
Annual Sales | 0 | 460,000 | 0 | ||
Annual Net Income | -44,490,000 | -5,800,000 | -47,730,000 | ||
Last Quarter Sales | 0 | 170,000 | 0 | ||
Last Quarter Net Income | -10,440,000 | -2,710,000 | -14,190,000 | ||
60-Month Beta | 1.65 | 0.86 | -0.17 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.18 on 03/06/25 | -0.15 on 04/14/25 | -1.16 on 03/11/25 | ||
Latest Earnings Date | 05/01/25 | 04/15/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |